1. Home
  2. AXR vs ONCY Comparison

AXR vs ONCY Comparison

Compare AXR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMREP Corporation

AXR

AMREP Corporation

HOLD

Current Price

$26.86

Market Cap

110.8M

Sector

Real Estate

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.91

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXR
ONCY
Founded
1961
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Homebuilding
Pharmaceuticals and Biotechnology
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.8M
94.0M
IPO Year
2010
2002

Fundamental Metrics

Financial Performance
Metric
AXR
ONCY
Price
$26.86
$0.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$30.00
$7.33
AVG Volume (30 Days)
10.8K
670.1K
Earning Date
03-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
89.60
N/A
EPS
1.68
N/A
Revenue
$12,831,000.00
N/A
Revenue This Year
$12.43
N/A
Revenue Next Year
$4.48
$2,505.00
P/E Ratio
$15.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$0.33
52 Week High
$29.00
$1.51

Technical Indicators

Market Signals
Indicator
AXR
ONCY
Relative Strength Index (RSI) 52.48 45.33
Support Level $20.56 $0.90
Resistance Level $28.48 $1.08
Average True Range (ATR) 1.27 0.06
MACD -0.22 0.00
Stochastic Oscillator 58.29 56.50

Price Performance

Historical Comparison
AXR
ONCY

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: